Lipella Pharmaceuticals LIPO Ratios (2021-2025)

LIPO
$0.00 +0.00 (+0.00%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Lipella Pharmaceuticals Quarterly Ratios

Periods 16 quarters
Latest Sep 2025

Lipella Pharmaceuticals ratios data for the quarter ended Sep 2025. These financial ratios cover 16 quarters of results from Dec 2021 through Sep 2025, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin -2,226.16%-241.00%-904.57%-1,442.39%-1,272.04%-570.07%-816.98%-687.63%-1,797.26%-830.14%-1,009.76%-1,530.65%
EBIT Margin -2,222.28%-237.91%-918.64%-1,476.62%-1,303.91%-603.76%-834.69%-697.93%-1,815.64%-835.68%-1,026.22%-1,564.19%
EBITDA Margin -603.16%-834.20%-697.40%-1,814.75%-835.26%-1,025.66%-1,563.36%
Operating Margin -2,222.28%-237.91%-918.64%-1,476.62%-1,303.91%-603.76%-834.69%-697.93%-1,815.64%-835.68%-1,026.22%-1,564.19%
Net Margin -2,226.16%-241.00%-904.57%-1,442.39%-1,272.04%-570.07%-816.98%-687.63%-1,797.26%4,946.77%-1,009.76%-1,530.65%
FCF Margin -2,109.95%-153.34%-913.18%-614.11%-662.52%-602.20%-951.77%-673.45%-812.52%-570.30%-1,102.19%-1,652.47%
Efficiency
Assets AverageAssets Avg. 5.28M4.05M3.17M3.21M3.36M2.66M2.17M2.42M3.76M4.29M3.04M
Equity AverageEquity Avg. 1.17M0.64M0.14M2.31M4.25M3.47M2.67M2.68M2.85M2.13M1.58M1.69M3.00M3.41M2.11M
Invested CapitalInvested Cap. 1.45M4.70M
Asset Utilization RatioAsset Util. 0.050.090.150.140.140.190.220.220.140.110.13
Leverage & Solvency
Interest Coverage RatioInterest Cover -455.29-477.47-431.12-76.37-201.04-288.82
Debt Ratio 0.020.00
Times Interest Earned -455.29-477.47-431.12-76.37-201.04-288.82
Valuation
Price to EarningsP/E 0.741.050.890.59
Price to SalesP/S 69.0241.6332.7218.1513.7310.917.109.456.879.938.557.11
Price to BookP/B 2.722.933.933.921.962.032.113.131.921.271.471.86
Enterprise Value 7.59M7.18M9.18M6.30M2.88M3.10M2.42M3.22M1.50M0.94M1.24M0.92M
Market Capitalization 12.71M11.20M12.29M8.71M6.18M5.21M3.60M4.57M3.69M5.16M4.02M2.77M
Return Ratios
Return on Sales [ROS]ROS -2,222.28%-237.91%-918.64%-1,476.62%-1,303.91%-603.76%-834.69%-697.93%-1,815.64%-835.68%-1,026.22%-1,564.19%-1,387.94%
Return on Capital Employed [ROCE]ROCE -64.35%-99.42%-167.23%-168.08%-173.93%-195.21%-296.33%-305.58%-173.71%-158.00%-226.11%
Return on Assets [ROA]ROA -55.42%-90.92%-135.66%-143.94%-141.28%-155.69%-196.28%-207.54%-136.28%-128.73%-175.61%
Return on Equity [ROE]ROE -112.63%-68.95%-106.15%-160.61%-172.15%-166.25%-194.25%-269.61%-296.96%-171.07%-161.87%-252.04%

Lipella Pharmaceuticals Ratios API

Pull Lipella Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=LIPO&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY